UrgentIQ Raises $15M for an Urgent Care AI Operating System

The United States now has 15,172 urgent care centers, and each one depends on software designed for work that rarely arrives on schedule. Five Elms Capital is putting $15M behind UrgentIQ's answer: connect the clinical, coding, payment, and collections work created by a walk-in visit before the next patient reaches the front desk.

UrgentIQ announced a $15M Series A growth investment from Five Elms Capital on September 11, 2026. The New York company said the capital will accelerate its urgent-care-specific electronic medical record, expand AI-supported clinical workflows, build more financial operations into the product, and grow the team. The valuation, security, ownership percentage, board rights, and any other Series A participants were not disclosed.

The investment matters because urgent care is becoming a larger and more consolidated delivery channel. Software in this market has to support the independent clinic trying to move patients faster and the multi-site operator trying to make documentation, coding, collections, and reporting behave consistently across an expanding footprint.

What Five Elms Invested In

UrgentIQ was founded in 2022 by Nathaniel “Nat” Gibbs, who remains founder and CEO. The company describes its product as an AI-native operating system for urgent care, combining patient engagement, scheduling, digital check-in, real-time insurance verification, clinical documentation, diagnosis and coding support, revenue-cycle management, payments, and practice analytics.

That scope reflects the economics of the setting. Urgent care centers do not separate the clinical encounter neatly from the administrative work surrounding it. Patient information affects eligibility. Documentation affects coding. Coding affects claims. Throughput affects how many visits a clinic can handle, while billing and collections determine whether the visit becomes revenue.

UrgentIQ and Five Elms report a 9.7/10 average customer-satisfaction rating and meaningful improvement in patient throughput among users. Those figures are company-reported. The announcement does not provide a customer count, revenue, retention, a uniform throughput percentage, or independent validation of the satisfaction score.

The company’s official product site shows a platform already covering intake, scheduling, documentation, e-prescribing, lab and radiology ordering, charge capture, claims, payments, denial management, and reporting. The Series A is intended to extend that base rather than finance a single feature.

The Series A Moves Billing Inside the Product

UrgentIQ said it will use the capital to develop a native billing module that brings revenue-cycle management fully in-house. The plan also includes advanced AI-supported diagnosis and coding, live insurance verification, an AI checkout agent, broader product development, and team expansion.

The billing move is commercially important because it removes a handoff while increasing UrgentIQ’s operating responsibility. A software vendor can integrate with a billing partner and still blame the seam when information is lost. A platform that owns more of the revenue cycle has more control over the workflow, but it also has to answer for claim quality, denials, payment timing, and collections.

UrgentIQ selected Inbox Health as a preferred patient-payments partner in February 2026. The planned native billing module does not make that relationship obsolete by itself, nor does it establish that every revenue-cycle function is already generally available. It shows where the company wants to concentrate product ownership after the financing.

Urgent Care Is a Large Operating Surface

The Urgent Care Association reports 15,172 urgent care centers in the United States serving more than 185M patient visits each year. Its current data shows the footprint grew from about 9,000 centers in 2016 to 15,000 in 2024, while average daily volume reached 33.96 visits per center in 2025.

Those figures create a substantial workflow market without making every clinic identical. Independent operators may prioritize implementation speed, fewer clicks, and tighter collections. Hospital-affiliated and multi-site groups also need permission controls, standardized templates, reporting, training, and the ability to compare performance across locations.

The buyer mix is shifting through consolidation. A Journal of Urgent Care Medicine analysis estimated that private-equity-backed operators controlled 2,622 urgent care rooftops as of May 12, 2025, equal to 18% of the 14,423 centers in its dataset. That older count uses a different date and methodology from the current UCA total, but it illustrates the direction: software choices increasingly move across networks instead of staying inside one office.

For UrgentIQ, that raises the value of a purpose-built platform and the cost of getting it wrong. A workaround that one clinic understands can become recurring training, compliance, reporting, and collections debt when repeated across dozens of sites.

Why Five Elms Fits the Round

Five Elms Capital invests in B2B software for specialized vertical markets. The firm reports more than $3B in assets under management, more than 80 professionals, and investments in more than 70 software platforms. Its operating model emphasizes product, retention, sales efficiency, executive hiring, and AI adoption alongside capital.

That makes UrgentIQ a recognizable Five Elms thesis. The investor is not betting only on AI inside healthcare. It is backing vertical software that can own a consequential workflow, serve customers with strong product expectations, and expand into more of the operating stack.

Joe Onofrio, a Five Elms Partner and co-chair of the firm’s Investment Committee, pointed to operator adoption and product satisfaction in the announcement. The public record does not disclose whether Five Elms received a board seat or how much ownership the $15M represents.

The Capital Record Requires Care

UrgentIQ has raised earlier private capital, but the public filing trail does not support a clean cumulative cash total. A 2025 Form D covered a $4.95M exempt offering and stated that part of the amount involved converted outstanding securities. Earlier filing records also document a 2023 offering.

Those amounts should not be added mechanically to the Series A and reported as total funding. The current event is a verified $15M Series A; cumulative financing, valuation, dilution, and the participation of prior investors remain undisclosed.

What UrgentIQ Has to Prove

The Series A gives UrgentIQ more capacity to build the system it says urgent care deserves. It does not establish that every planned module is deployed, that the company’s customer metrics are independently audited, or that a single platform can remove every operational handoff across clinical care and reimbursement.

The useful evidence will appear in operator outcomes: implementation time, patient throughput, documentation quality, coding accuracy, denial rates, collection speed, provider adoption, uptime, and consistent performance across locations. Larger groups will also test whether UrgentIQ can standardize workflows without flattening the local differences that make urgent care clinics function.

Five Elms is financing UrgentIQ to take responsibility for more of the visit after the waiting-room door opens. Each new clinic will add another version of the same demanding sequence, from patient arrival to signed chart to paid claim, and that sequence is where the company’s wider operating-system ambition will become measurable.